QxMD
QxMD is a Vancouver-based medical technology company that builds mobile clinical decision support apps — Read by QxMD and Calculate by QxMD — reaching over one million practicing healthcare professionals, and sells enterprise research dissemination and institutional subscription solutions to hospitals, universities, publishers, and conference organizers.
- Company typePrivate
- Founded2009
- HeadquartersVancouver, Canada
- Headcount11–50
- GTM typeB2B and B2C
- OfferingSoftware
What QxMD does
QxMD is a Vancouver, Canada-based medical technology company founded in 2009 that builds mobile-first clinical decision support tools designed to translate medical research into point-of-care practice. The company's product portfolio centers on two flagship consumer applications — Read by QxMD, a personalized medical and scientific journal reader that aggregates millions of research citations, and Calculate by QxMD, a point-of-care clinical calculator offering more than 400 decision support tools for prognosis, diagnosis, and patient management. Both applications are distributed natively across iOS, Android, and web, giving the company a cross-platform distribution footprint aimed at individual practicing healthcare professionals.
Beyond its consumer applications, QxMD operates a portfolio of enterprise and B2B solutions that monetize the platform's reach to clinicians. Read Institutional Edition is sold as a subscription to hospitals, universities, and healthcare organizations seeking to maximize the value of their digital journal subscriptions. The company also offers Research Dissemination, Interactive Tools, Guideline Digitization, Conference Promotion, and Services for Medical Journals — solutions designed to help researchers, guideline bodies, publishers, and event organizers push evidence-based content to frontline clinicians. The company's claimed reach exceeds 1 million practicing healthcare providers, with an annual engaged community of approximately 2 million users.
QxMD's revenue model combines a freemium consumer channel (free mobile applications with optional upgrade paths) with recurring enterprise subscriptions for institutional customers and bespoke engagements with publishers, conferences, and guideline developers. The company is privately held, employs between 11 and 50 people, and has not disclosed funding rounds, revenue, or pricing. No patents, certifications, or third-party AI/ML capabilities are documented in available sources. Leadership signals are limited — Chan Kruse is identified as CTO and co-founder.
QxMD firmographics
Firmographics- Name
- QxMD
- Legal name
- QxMD
- Website
- https://QxMD.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- QxMD is a Vancouver-based medical technology company that builds mobile clinical decision support apps — Read by QxMD and Calculate by QxMD — reaching over one million practicing healthcare professionals, and sells enterprise research dissemination and institutional subscription solutions to hospitals, universities, publishers, and conference organizers.
- Ownership category
- akta.pro rank
QxMD industry classification
Industry- Product category
- Clinical Decision Support Software
- NAICS
- Software Publishers (5132)
- akta.pro primary industry
- Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF)
- akta.pro secondary industry
- Healthcare & Wellness Personalization (HDAAAGAI)
Keywords
Where QxMD is headquartered
LocationHeadquarters
- HQ city
- Vancouver
- HQ country
- Canada
- HQ region
- North America
Markets served
QxMD business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Consumer Mobile Apps: Freemium mobile applications (Read by QxMD, Calculate by QxMD) distributed through iOS App Store and Google Play Store. Individual healthcare professionals can download and use the apps.
- Institutional/Enterprise Subscriptions: Read Institutional Edition sold to hospitals, universities, and healthcare organizations to maximize value from digital journal subscriptions and drive practice change.
Go-to-market motion2 records
Distribution channels5 records
Marketing channels5 records
QxMD product offering
Product offeringCore offering
QxMD builds and operates a mobile-first clinical decision support platform for healthcare professionals. Its core consumer offerings are Read by QxMD, a personalized medical and scientific journal reader, and Calculate by QxMD, a point-of-care calculator with over 400 decision support tools for prognosis, diagnosis, and patient management. For organizations, QxMD sells an Institutional Edition, research dissemination services, guideline digitization, interactive tools, conference promotion, and solutions for medical journals.
Product overview
QxMD is a mobile-first healthcare technology platform offering a portfolio of consumer apps and enterprise solutions. The core consumer products are Read by QxMD (personalized medical journal article reader) and Calculate by QxMD (clinical calculator with 400+ point-of-care tools), available across iOS, Android, and Web. Enterprise/organizational solutions include Read Institutional Edition, Contributor Network, Research Dissemination, Interactive Tools, Guideline Digitization, Conference Promotion, and Services for Medical Journals — all designed to help researchers, hospitals, universities, medical journals, and conference organizers disseminate clinical evidence to practicing healthcare providers. The platform serves over 1 million healthcare professionals.
Differentiator
Problem solved
Functional benefit
Brands
- Read by QxMD: Mobile application helping healthcare professionals stay on top of the most important and cutting-edge research
- Calculate by QxMD
- Read, Institutional Edition
Products and services
- Read by QxMD
Quantifiable outcome
- Reaching >1 million practicing healthcare providers with clinical research
- +1 more outcomes
Companies that use QxMD
Customer profileSegments7 records
Ideal customer profiles6 records
QxMD technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
QxMD partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights5 records
QxMD competitors and assessment
Company assessmentDirect peers
- VisualDx: VisualDx provides a clinical decision support system focused on differential diagnosis using image-based and clinical findings. Like QxMD, it is mobile-first, targets practicing clinicians, and monetizes through institutional subscriptions alongside consumer access.
- Epocrates: Owned by athenahealth, Epocrates is a long-standing mobile clinical reference app for physicians, including drug information, interaction checkers, and calculators. It directly competes with QxMD's Read and Calculate apps for clinician mindshare and app-store real estate.
- PEPID: PEPID offers point-of-care clinical decision support content, drug interaction tools, and medical calculators used by clinicians in hospitals and schools. It overlaps directly with QxMD Calculate and the institutional/educational buyer segments QxMD serves.
- Skyscape: Skyscape provides mobile medical reference apps and decision support tools for clinicians, with an app-store distribution model similar to QxMD. It competes directly for the same physician user base and offers comparable point-of-care calculators and references.
Broad incumbents
- DynaMed: Owned by EBSCO, DynaMed is an evidence-based clinical reference tool for point-of-care use, marketed to hospitals and clinicians. It directly competes with QxMD's positioning as a clinical knowledge translation layer and is sold through similar institutional channels.
- UpToDate: Operated by Wolters Kluwer, UpToDate is the dominant evidence-based clinical decision support resource used by hospitals and physicians worldwide. It competes with QxMD's point-of-care decision support offering and is frequently purchased by the same institutional buyers QxMD targets.
- Wolters Kluwer: Wolters Kluwer Health owns UpToDate and a portfolio of clinical decision support and medical education products. It is the dominant incumbent QxMD competes against for institutional budgets and a likely strategic acquirer given the overlap in physician end users.
- Medscape: WebMD's Medscape is a leading free medical reference platform for physicians, including news, clinical calculators, and CME. It overlaps with QxMD's clinician-targeted content delivery and freemium app strategy, and competes for the same daily-engagement audience.
Emerging players
- Isabel Healthcare: Isabel offers a differential diagnosis decision support tool used by clinicians at the point of care. Like QxMD Calculate, it focuses on translating clinical knowledge into workflow tools and is sold to hospitals and physician groups.
- AMBOSS: AMBOSS provides a clinical knowledge platform combining medical references, calculators, and decision support with strong adoption among medical students and residents. It overlaps with QxMD's positioning among trainee clinicians and institutional academic customers.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights5 records
Customer concentration
QxMD social profiles
Digital presenceQxMD financial estimates
Financial estimateRevenue estimate
Valuation estimate
QxMD leadership team
Management profileNumber of profiles
Profiles1 record
QxMD funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
QxMD M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about QxMD
What does QxMD do?
QxMD builds and operates a mobile-first clinical decision support platform for healthcare professionals. Its core consumer offerings are Read by QxMD, a personalized medical and scientific journal reader, and Calculate by QxMD, a point-of-care calculator with over 400 decision support tools for prognosis, diagnosis, and patient management. For organizations, QxMD sells an Institutional Edition, research dissemination services, guideline digitization, interactive tools, conference promotion, and solutions for medical journals.
Is QxMD a public or private company?
QxMD is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was QxMD founded?
QxMD was founded in 2009. It employs 11 to 50 people.
Where is QxMD based?
QxMD is headquartered in Vancouver, Canada, in the North America region.
How does QxMD make money?
Two revenue lines are on record. Consumer Mobile Apps are the primary driver. The others are institutional/Enterprise Subscriptions.
Who are QxMD's main competitors?
Direct peers on record are VisualDx, Epocrates, PEPID and Skyscape. Broad incumbents are DynaMed, UpToDate, Wolters Kluwer and Medscape. Emerging players are Isabel Healthcare and AMBOSS.
Does QxMD have an API?
No public API is recorded for QxMD.
What industry is QxMD in?
QxMD's product category is Clinical Decision Support Software. Its primary akta.pro industry code is HLAGAJAF, Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D), with a secondary code of HDAAAGAI, Healthcare & Wellness Personalization. Its NAICS code is 5132.